Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Registry for Berinert®, a C1-Esterase Inhibitor

NCT01108848 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT01108848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01108848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Lead sponsor
CSL Behring
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2014
Enrollment
318 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

includes: hereditary angioedema